These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34718756)

  • 1. Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure.
    Neradova A; Wasilewski G; Prisco S; Leenders P; Caron M; Welting T; van Rietbergen B; Kramann R; Floege J; Vervloet MG; Schurgers LJ
    Nephrol Dial Transplant; 2022 Mar; 37(4):652-662. PubMed ID: 34718756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
    Grzejszczak P; Kurnatowska I
    Kidney Blood Press Res; 2021; 46(5):523-530. PubMed ID: 34247173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
    Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
    Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.
    De Vriese AS; Caluwé R; Pyfferoen L; De Bacquer D; De Boeck K; Delanote J; De Surgeloose D; Van Hoenacker P; Van Vlem B; Verbeke F
    J Am Soc Nephrol; 2020 Jan; 31(1):186-196. PubMed ID: 31704740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Role of Vitamin K-With Particular Emphasis on Cardiovascular and Renal Aspects.
    Stępień A; Koziarska-Rościszewska M; Rysz J; Stępień M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
    Zaragatski E; Grommes J; Schurgers LJ; Langer S; Kennes L; Tamm M; Koeppel TA; Kranz J; Hackhofer T; Arakelyan K; Jacobs MJ; Kokozidou M
    Kidney Int; 2016 Mar; 89(3):601-11. PubMed ID: 26466318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of kidney transplantation and phosphate binder use in vitamin K status.
    Jansz TT; Neradova A; van Ballegooijen AJ; Verhaar MC; Vervloet MG; Schurgers LJ; van Jaarsveld BC
    PLoS One; 2018; 13(8):e0203157. PubMed ID: 30161193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
    Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study.
    Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimbürger O; Jørgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P
    PLoS One; 2021; 16(2):e0247623. PubMed ID: 33626087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vitamin K status and rationale for vitamin K supplementation in dialysis patients.
    Caluwé R; Verbeke F; De Vriese AS
    Nephrol Dial Transplant; 2020 Jan; 35(1):23-33. PubMed ID: 30590803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.
    Neradova A; Schumacher SP; Hubeek I; Lux P; Schurgers LJ; Vervloet MG
    BMC Nephrol; 2017 May; 18(1):149. PubMed ID: 28464802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Vitamin K in Vascular Calcification.
    Cozzolino M; Fusaro M; Ciceri P; Gasperoni L; Cianciolo G
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):437-444. PubMed ID: 31831122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.
    Roumeliotis S; Roumeliotis A; Georgianos PI; Thodis E; Schurgers LJ; Maresz K; Eleftheriadis T; Dounousi E; Tripepi G; Mallamaci F; Liakopoulos V
    PLoS One; 2022; 17(8):e0273102. PubMed ID: 35976944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
    Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
    Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation.
    Kaesler N; Magdeleyns E; Herfs M; Schettgen T; Brandenburg V; Fliser D; Vermeer C; Floege J; Schlieper G; Krüger T
    Kidney Int; 2014 Aug; 86(2):286-93. PubMed ID: 24429407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.
    Krueger T; Schlieper G; Schurgers L; Cornelis T; Cozzolino M; Jacobi J; Jadoul M; Ketteler M; Rump LC; Stenvinkel P; Westenfeld R; Wiecek A; Reinartz S; Hilgers RD; Floege J
    Nephrol Dial Transplant; 2014 Sep; 29(9):1633-8. PubMed ID: 24285427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is the Evidence?
    Roumeliotis S; Liakopoulos V; Schurgers LJ
    Curr Vasc Pharmacol; 2022; 20(2):121-126. PubMed ID: 35139790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.